-
Floridians will experience a partial eclipse on Monday afternoon. Looking directly at the sun during the event even for a few seconds isn't worth the risk. It can burn retina cells and lead to solar retinopathy.
-
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
-
To treat amblyopia, doctors typically prescribe a patch to cover the stronger eye and make the brain learn to work with the weaker one. Virtual reality offers a new approach.
-
Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas.
-
This week on What’s Health Got To Do With It, we learn about the field of pediatric eye health from Jacksonville ophthalmologist Dr. Michelle Attzs.
-
Americans think losing their eyesight would be one of the worst possible health outcomes, yet millions lack a fundamental understanding of eye health.
-
Kids are focusing too close for too long and their eyes are actually growing to focus the light for things that are near. But it’s blurring their vision for distance.
-
The teen was born with a rare genetic condition that causes blisters all over his body and in his eyes. But his skin improved when he joined a clinical trial to test the world’s first topical gene therapy. His doctor wondered if it could be adapted for his eyes.
-
Some nasty eye infections in California led health officials to link a superbug bacteria to potentially contaminated eyedrops imported from India. At last count, 58 Americans in 13 states have been infected.
-
Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake.